Open AccessS235: A TWO‐PART, SINGLE‐ AND TWO‐ARM RANDOMIZED, OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES
Author(s) -
dertschnig S.,
finke J.,
heim D.,
schanz U.,
holler E.,
holtick U.,
socié G.,
teshima T.,
bucher C.,
passweg J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843832.53729.72
Subject(s) - tolerability , medicine , hematopoietic stem cell transplantation , clinical trial , pharmacology , oncology , leukemia , transplantation , immune system , adverse effect , immunology